Prime Medicine Inc (PRME)
5.26
-0.31
(-5.57%)
USD |
NASDAQ |
May 08, 14:55
Prime Medicine Net Income (Quarterly): -65.64M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -65.64M |
| September 30, 2023 | -50.71M |
| June 30, 2023 | -42.38M |
| March 31, 2023 | -39.40M |
| December 31, 2022 | -39.28M |
| September 30, 2022 | -29.35M |
| Date | Value |
|---|---|
| June 30, 2022 | -29.35M |
| March 31, 2022 | -23.84M |
| December 31, 2021 | -62.91M |
| September 30, 2021 | -16.41M |
| December 31, 2019 | -2.529M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-65.64M
Minimum
Dec 2023
-2.529M
Maximum
Dec 2019
-36.53M
Average
-39.28M
Median
Dec 2022
Net Income (Quarterly) Benchmarks
| 10x Genomics Inc | -59.95M |
| Verve Therapeutics Inc | -48.35M |
| Ionis Pharmaceuticals Inc | -9.263M |
| Solid Biosciences Inc | -20.34M |
| Beam Therapeutics Inc | 142.80M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 54.54M |
| EPS Diluted (Quarterly) | -0.72 |
| Enterprise Value | 546.90M |
| Earnings Yield | -41.44% |